• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mineralys Therapeutics, Inc. - Common Stock (NQ:MLYS)

14.91 +1.03 (+7.42%)
Streaming Delayed Price Updated: 2:02 PM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 396,704
Open 14.06
Bid (Size) 14.90 (4)
Ask (Size) 14.98 (4)
Prev. Close 13.88
Today's Range 13.97 - 15.15
52wk Range 8.241 - 18.38
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Mineralys Therapeutics: Investigational Drug Shows Benefit In Hypertensive Patients With Chronic Kidney Disease, Stock Jumps
June 17, 2025
Mineralys reports Phase 2 trial success for lorundrostat, showing BP and kidney improvements in CKD patients with favorable safety results. 
Via Benzinga
This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
June 11, 2025
 
Via Benzinga

Performance

YTD
+21.7%
+21.7%
1 Month
+10.2%
+10.2%
3 Month
+7.0%
+7.0%
6 Month
+51.2%
+51.2%
1 Year
+16.2%
+16.2%

More News

Read More
Earnings Scheduled For May 12, 2025
May 12, 2025
Via Benzinga
Uncovering Potential: Mineralys Therapeutics's Earnings Preview
May 09, 2025
Via Benzinga
Mineralys, Sana, Aeon: These 3 Biotech Stocks Saw The Sharpest Retail Interest Spike In Q1
April 01, 2025
Via Stocktwits
Earnings Scheduled For February 12, 2025
February 12, 2025
Via Benzinga
Insights into Mineralys Therapeutics's Upcoming Earnings
November 08, 2024
Via Benzinga
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week
March 16, 2025
Via Stocktwits
Unusual volume stocks are being observed in Wednesday's session.
March 12, 2025
Via Chartmill
Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
March 12, 2025
Via Benzinga
Keep an eye on the top gainers and losers in Monday's session.
March 10, 2025
Via Chartmill
Monday's session: top gainers and losers
March 10, 2025
Via Chartmill
Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate
March 10, 2025
Via Benzinga
Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher
March 10, 2025
Via Benzinga
Topics Stocks
Let's uncover which stocks are experiencing notable gaps during today's session.
March 10, 2025
Via Chartmill
Redfin, Mineralys Therapeutics, Trevi Therapeutics And Other Big Stocks Moving Higher On Monday
March 10, 2025
Via Benzinga
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket
March 10, 2025
Via Benzinga
Which stocks are moving after the closing bell on Friday?
March 07, 2025
Via Chartmill
Ford, Skyworks Solutions, FormFactor And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
February 06, 2025
Via Benzinga
Why F5 Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
January 29, 2025
Via Benzinga
Ericsson Posts Weak Results, Joins East West Bancorp And Other Big Stocks Moving Lower In Friday's Pre-Market Session
January 24, 2025
Via Benzinga
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
January 24, 2025
Via Benzinga
Earnings Scheduled For November 11, 2024
November 11, 2024
Via Benzinga
MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!
September 20, 2024
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!
September 12, 2024
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire

Frequently Asked Questions

Is Mineralys Therapeutics, Inc. - Common Stock publicly traded?
Yes, Mineralys Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Mineralys Therapeutics, Inc. - Common Stock trade on?
Mineralys Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Mineralys Therapeutics, Inc. - Common Stock?
The ticker symbol for Mineralys Therapeutics, Inc. - Common Stock is MLYS on the Nasdaq Stock Market
What is the current price of Mineralys Therapeutics, Inc. - Common Stock?
The current price of Mineralys Therapeutics, Inc. - Common Stock is 14.91
When was Mineralys Therapeutics, Inc. - Common Stock last traded?
The last trade of Mineralys Therapeutics, Inc. - Common Stock was at 07/30/25 02:02 PM ET
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap